Advanced Healthcare Materials
© WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Editor-in-Chief: Lorna Stimson
Online ISSN: 2192-2659
Associated Title(s): Advanced Electronic Materials, Advanced Energy Materials, Advanced Engineering Materials, Advanced Functional Materials, Advanced Materials, Advanced Materials Interfaces, Advanced Optical Materials, Advanced Science, Biotechnology Journal, ChemMedChem, Journal of Interdisciplinary Nanomedicine, Macromolecular Bioscience, Particle & Particle Systems Characterization, Small
Materials Science Weekly Newsletter
Our newsletter signup is currently down for maintenance. It will be back online soon!
Recently Published Articles
- Biological and Tribological Assessment of Poly(Ethylene Oxide Terephthalate)/Poly(Butylene Terephthalate), Polycaprolactone, and Poly (L\DL) Lactic Acid Plotted Scaffolds for Skeletal Tissue Regeneration
Wilhelmus J. Hendrikson, Xiangqiong Zeng, Jeroen Rouwkema, Clemens A. van Blitterswijk, Emile van der Heide and Lorenzo Moroni
Article first published online: 25 NOV 2015 | DOI: 10.1002/adhm.201500067
Poly(caprolactone), poly(L/DL)lactic-acid and poly(ethylene oxide terephthalate)/poly(butylene terephthalate) scaffolds are tested for their biological and tribological behavior. The biomaterials are compared biologically by exposing stem-cell-seeded scaffolds to differentiation media. The effects of biomaterial and scaffold architecture on friction are assessed. The best performing biomaterial and architecture are combined to investigate the influence of extracellular matrix formation on friction coefficient.
- Sensing and Sensibility: Single-Islet-based Quality Control Assay of Cryopreserved Pancreatic Islets with Functionalized Hydrogel Microcapsules
Wanyu Chen, Zhiquan Shu, Dayong Gao and Amy Q. Shen
Article first published online: 25 NOV 2015 | DOI: 10.1002/adhm.201500515
The single-islet-based quality control assay consists of a droplet microfluidic device for islet encapsulation with alginate hydrogel, with oxygen sensitive dye embedded in the capsules for quality control, with an optimized cryopreservation protocol.
- Exploring the Potential of Starch/Polycaprolactone Aligned Magnetic Responsive Scaffolds for Tendon Regeneration
Ana I. Gonçalves, Márcia T. Rodrigues, Pedro P. Carvalho, Manuel Bañobre-López, Elvira Paz, Paulo Freitas and Manuela E. Gomes
Article first published online: 25 NOV 2015 | DOI: 10.1002/adhm.201500623
3D rapid prototyped scaffolds with aligned architecture and magnetic responsiveness promote tenogenic differentiation of adipose stem cells with increasing ECM deposition stimulated by an externally applied magnetic field. The magnetic scaffolds also show biocompatibility in an ectopic rat model. These findings guide the rational design of magnetically responsive scaffolds mimicking tendon microenvironment and enabling the combination of therapeutic and diagnostic tools.
- Gallium-Loaded Dissolvable Microfilm Constructs that Provide Sustained Release of Ga3+ for Management of Biofilms
Maggie Herron, Michael J. Schurr, Christopher J. Murphy, Jonathan F. McAnulty, Charles J. Czuprynski and Nicholas L. Abbott
Article first published online: 24 NOV 2015 | DOI: 10.1002/adhm.201500599
Bacterial biofilms have been shown to delay the healing of wounds. Here, the incorporation of the antibiofilm agent Ga3+ into polymeric nanofilms, modification of the nanofilms by cross-linking to control the release rate of Ga3+, integration of the nanofilms onto wound dressings using micrometer-thick water-soluble casts, and the effectiveness of the nanofilms in inhibiting and dispersing biofilms are reported.
- An Apoferritin-based Drug Delivery System for the Tyrosine Kinase Inhibitor Gefitinib
Anchala I. Kuruppu, Lei Zhang, Hilary Collins, Lyudmila Turyanska, Neil R. Thomas and Tracey D. Bradshaw
Article first published online: 23 NOV 2015 | DOI: 10.1002/adhm.201500389
Anticancer drug Gefitinib encapsulated within human heavy chain apoferritin by diffusion allows pH-controlled sustained release of cargo. The combination of increased cellular uptake, and potent and enhanced antitumor activity against the HER2 overexpressing SKBR3 cell line compared to Gefitinib alone, makes it a promising carrier for delivery of drugs to tumor sites.